Trial Profile
A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs GSK 2239633 (Primary)
- Indications Asthma
- Focus First in man; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 05 Dec 2014 New trial record